Infliximab/ipilimumab/methylprednisoloneAcneiform skin rash, diarrhoea and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1907卷 / 1期

关键词：

D O I：

10.1007/s40278-022-15516-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：257 / 257

相关论文

共 50 条

[1] Ipilimumab/nivolumabColitis, diarrhoea and skin rash: case report
[J]. Reactions Weekly, 2019, 1739 (1) : 158 - 158
[2] Infliximab/ipilimumab/nivolumabColitis and lack of efficacy: case report
[J]. Reactions Weekly, 2021, 1836 (1) : 419 - 419
[3] Infliximab/prednisoloneBloody diarrhoea with abdominal pain and lack of efficacy: case report
[J]. Reactions Weekly, 2023, 1980 (1) : 216 - 216
[4] Ipilimumab/nivolumab/pembrolizumabLack of efficacy, uveitis and skin rash: case report
[J]. Reactions Weekly, 2023, 1946 (1) : 307 - 307
[5] Infliximab/sulfasalazineNephrotic syndrome, glairo-bloody diarrhoea and skin rash: case report
[J]. Reactions Weekly, 2018, 1712 (1) : 289 - 289
[6] Multiple drugDysrhythmias, skin rash and lack of efficacy: case report
[J]. Reactions Weekly, 2023, 1944 (1) : 369 - 369
[7] AxitinibPolycythaemia, diarrhoea and skin rash: case report
[J]. Reactions Weekly, 2019, 1766 (1) : 68 - 68
[8] AntineoplasticsLack of efficacy, diarrhoea and rash: case report
[J]. Reactions Weekly, 2023, 1974 (1) : 50 - 50
[9] Ipilimumab/nivolumabHepatitis and lack of efficacy: case report
[J]. Reactions Weekly, 2022, 1926 (1) : 276 - 276
[10] Ipilimumab/nivolumabColitis and lack of efficacy: case report
[J]. Reactions Weekly, 2022, 1903 (1) : 214 - 214

← 1 2 3 4 5 →